BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2440564)

  • 21. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents.
    Rostom SA; Ashour HM; Abd El Razik HA
    Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
    Yin H; Xu Y; Qian X; Li Y; Liu J
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents.
    Bhat BA; Dhar KL; Puri SC; Saxena AK; Shanmugavel M; Qazi GN
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3177-80. PubMed ID: 15893928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells.
    Sullivan DM; Latham MD; Ross WE
    Cancer Res; 1987 Aug; 47(15):3973-9. PubMed ID: 3038304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents.
    Kock I; Heber D; Weide M; Wolschendorf U; Clement B
    J Med Chem; 2005 Apr; 48(8):2772-7. PubMed ID: 15828815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents.
    Mirzayans R; Andrais B; Scott A; Tessier A; Murray D
    J Pharm Pharm Sci; 2007; 10(2):298s-311s. PubMed ID: 17718933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
    Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
    Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
    Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
    Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and antiproliferative activity of some new azapyranoxanthenone aminoderivatives.
    Kolokythas G; Pouli N; Marakos P; Pratsinis H; Kletsas D
    Eur J Med Chem; 2006 Jan; 41(1):71-9. PubMed ID: 16300857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships.
    Ohsumi K; Nakagawa R; Fukuda Y; Hatanaka T; Morinaga Y; Nihei Y; Ohishi K; Suga Y; Akiyama Y; Tsuji T
    J Med Chem; 1998 Jul; 41(16):3022-32. PubMed ID: 9685242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and cytotoxic and antitumor activity of esters in the 1,2-dihydroxy-1,2-dihydroacronycine series.
    Elomri A; Mitaku S; Michel S; Skaltsounis AL; Tillequin F; Koch M; Pierré A; Guilbaud N; Léonce S; Kraus-Berthier L; Rolland Y; Atassi G
    J Med Chem; 1996 Nov; 39(24):4762-6. PubMed ID: 8941390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyrimido[4,5,6-kl]acridines. Synthesis, in vitro cytotoxicity and structure-activity relationships.
    Antonini I; Polucci P; Martelli S
    Anticancer Drug Des; 1999 Oct; 14(5):451-9. PubMed ID: 10766300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protodioscin (NSC-698 796): its spectrum of cytotoxicity against sixty human cancer cell lines in an anticancer drug screen panel.
    Hu K; Yao X
    Planta Med; 2002 Apr; 68(4):297-301. PubMed ID: 11988850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of novel amino-substituted xanthenones and benzo[b]xanthenones: evaluation of their antiproliferative activity and their ability to overcome multidrug resistance toward MES-SA/D x 5 cells.
    Kostakis IK; Pouli N; Marakos P; Skaltsounis AL; Pratsinis H; Kletsas D
    Bioorg Med Chem; 2006 May; 14(9):2910-34. PubMed ID: 16376546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ability to overcome multidrug resistance of tumor cell lines by novel acridine cytostatics with condensed heterocyclic rings.
    Bontemps-Gracz MM; Kupiec A; Antonini I; Borowski E
    Acta Biochim Pol; 2002; 49(1):87-92. PubMed ID: 12136960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
    J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
    Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.